Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FCP1W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $68,385
Award facts
- Contract value 100% obligated
- $68,384.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $68,384.57 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 300 mg/2 mL pen injectors on November 13, 2025, with completion expected by November 14, 2025. This firm fixed-price, non-competitive delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements through open competition.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical supply chains, particularly supporting military and veteran healthcare systems. Dupixent is a specialty biologic medication used to treat moderate-to-severe eczema, asthma, and chronic rhinosinusitis, medications essential for the Defense Health Agency and U.S. military medical programs. As the prime contractor on this delivery order, AmerisourceBergen leverages its comprehensive pharmaceutical distribution network and established relationship with DLA to fulfill federal medical supply needs across multiple therapeutic domains on behalf of military healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DR26FCP1W?
SPE2DR26FCP1W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FCP1W worth?
The government has obligated $68,385 on SPE2DR26FCP1W.
Is contract SPE2DR26FCP1W an order under another contract?
Yes. SPE2DR26FCP1W is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCP1W competed?
The extent of competition for SPE2DR26FCP1W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award